Related Experiment Video
Updated: Jul 15, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
[Cutaneous manifestations during treatment with TNF-alpha blockers: 11 cases]
D Lebas1, D Staumont-Sallé, E Solau-Gervais
1Clinique de Dermatologie, Hôpital Claude Huriez, CHRU Lille, Lille Cedex.
Background:
TNFalpha blockers have recently extended the therapeutic arsenal available in dermatology. However, dermatologists must be informed of their potential adverse dermatological effects. While the chief adverse effect of TNFalpha blockers is risk of infection, cutaneous adverse effects have not yet been clearly elucidated and publications on this topic are few and far between. The aim of our study is to report various dermatological problems noted during treatment with TNFalpha blockers.
Patients And Methods:
This was a retrospective study of patient files. The study population comprised patients receiving TNFalpha blockers and presenting cutaneous reaction, and seen in the dermatology department between August 2001 and December 2004.
Results:
Eleven patients were included. The following cutaneous reactions were seen: delayed skin rash (1 case), lupus syndrome (1 case), cutaneous vasculitis (2 cases), palmoplantar pustulosis (2 cases), psoriasis vulgaris (1 case), atopic dermatitis (1 case), lichenoid rash (1 case), purpuric capillaritis (1 case) and melanoma (1 case).
Discussion:
The cutaneous manifestations seen represented a wide range of different clinical pictures. Dermatologists must be aware of these potential adverse effects. Future improvement of knowledge of the physiopathological mechanisms as well as the institution of prospective cohort studies should provide clearer guidance on the management of such symptoms.
Insights
Tumor necrosis factor-alpha (TNFα) blockers can cause various skin reactions. Dermatologists should monitor patients for these potential adverse dermatological effects during treatment.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Context:
- Tumor necrosis factor-alpha (TNFα) blockers are increasingly used in dermatology.
- Adverse dermatological effects of TNFα blockers are not well-documented.
- Understanding these side effects is crucial for patient safety.
Purpose:
- To report the spectrum of cutaneous adverse events observed in patients treated with TNFα blockers.
- To raise awareness among dermatologists regarding potential skin reactions.
Summary:
- A retrospective study identified eleven patients experiencing cutaneous reactions while on TNFα blockers.
- Observed reactions included lupus syndrome, vasculitis, pustulosis, psoriasis, atopic dermatitis, lichenoid rash, purpuric capillaritis, and melanoma.
- Delayed skin rash was also noted.
Impact:
- Highlights the diverse range of potential dermatological side effects associated with TNFα blockers.
- Emphasizes the need for dermatologists to be vigilant for these adverse reactions.
- Suggests further research into physiopathological mechanisms and prospective studies for better management.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug Toxicity: Allergic Reactions
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Acne Infection
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Ulcerative Colitis